The ACTIVE pursuit of stroke prevention in patients with atrial fibrillation

New England Journal of Medicine

Volumn 360, Issue 20, 2009, Pages 2127-2129

  Go, Alan S ^a  

^a Aiser Permanente of Northern California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL; IRBESARTAN; PLACEBO; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE; VITAMIN K GROUP;

ADD ON THERAPY; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; DRUG ANTAGONISM; DRUG COMBINATION; NOTE; STROKE;

ASPIRIN; ATRIAL FIBRILLATION; DRUG THERAPY, COMBINATION; HUMANS; PLATELET AGGREGATION INHIBITORS; STROKE; TICLOPIDINE; VITAMIN K;

EID: 65649089442     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0902676     Document Type: Editorial

References (15)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375 (Pubitemid 32424106)
2. Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:Suppl:546S-592S.
3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-867
4. Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 2003;290:2685-2692
5. Fang MC, Go AS, Chang Y, Borowsky L, Pomernacki NK, Singer DE. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol 2008;51:810-815
6. Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006;151:713-719
7. Devereaux PJ, Anderson DR, Gardner MJ, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation. BMJ 2001;323:1218-1222 (Pubitemid 33097314)
8. Boulanger L, Kim J, Friedman M, Hauch O, Foster T, Menzin J. Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice. Int J Clin Pract 2006;60:258-264 (Pubitemid 43337604)
9. The ACTIVE Investigators. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009;360:2066-2078
10. Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006;367:1903-1912.
11. Connolly S, Yusuf S, Budaj A, et al. Rationale and design of ACTIVE: the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events. Am Heart J 2006;151:1187-1193 (Pubitemid 44172865)
12. Man-Son-Hing M, O'Connor AM, Drake E, Biggs J, Hum V, Laupacis A. The effect of qualitative vs. quantitative presentation of probability estimates on patient decision-making: a randomized trial. Health Expect 2002;5:246-255 (Pubitemid 34988190)
13. Bousser MG, Bouthier J, Büller HR, et al. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. Lancet 2008;371:315-321
14. Albers GW, Diener HC, Frison L, et al. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. JAMA 2005;293:690-698 (Pubitemid 40220342)
15. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870 (Pubitemid 32537350)